SI BONE Inc (SIBN) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company...

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023

SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods

SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based...

SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023

SANTA CLARA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities